Clinical Trial Update: Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults With Erythrocouperosis [NA]

View source ↗

Summary

The exploratory study evaluating Dermo-cosmetic RV5026B for 2 months in adults with erythrocouperose associated with pityriasis folliculorum of the face was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythrocouperose
• Pityriasis Folliculorum of the Face

Drugs mentioned

• RV5026B

Snippet

Sponsor: Pierre Fabre Dermo Cosmetique | Conditions: Erythrocouperose Associated With Pityriasis Folliculorum of the Face | NA | Status: TERMINATED